Medivir will merge its Research and Development unit and implement changes within the management Group. The company has announces that, as the next step in the company’s optimisation process, its research and development operations will be merged into a …

Christine Lind new CEO of Medivir AB effective 1 April 2017. Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces today that Christine Lind has been appointed as the new CEO of Medivir AB.She succeeds Niklas Prager, who accepted the role as CEO in 2014 from a position as a Director of the Board when the company faced the need of a corporate transformation.

Visa profilmärken. Prager will succeed Maris Hartmanis who now leaves the position of President and CEO of Medivir. Niklas Prager holds a Degree of Master of Science in Business Administration and Economics from the Stockholm School of Economics, and has held a variety of different positions, mainly in the pharmaceutical industry, throughout his career, according to Medivir. Niklas Prager, outgoing CEO of Medivir AB, mobile +46 768117744. Christine Lind, CEO Designate of Medivir AB, mobile +46 727102205. Anna Malm Bernsten, Chairman of the Board of Medivir AB, mobile +46 705598541. This information is information that Medivir AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Niklas Prager, outgoing CEO of Medivir AB, mobile +46 768117744 Christine Lind, CEO Designate of Medivir AB, mobile +46 727102205 Anna Malm Bernsten, Chairman of the Board of Medivir AB, mobile +46 705598541. This information is information that Medivir AB is obliged to make public pursuant to the EU Market Abuse Regulation. Niklas Prager börjar på Medivir Bolagets styrelse har utsett Niklas Prager till ny verkställande direktör och koncernchef för Medivir. Han tillträder den 1 september och efterträder då Maris Hartmanis som varit bolagets vd sedan 2011 Niklas Prager valdes in i Medivirs styrelse i maj i år och är därmed väl insatt i bolagets styrelse, enligt ett pressmeddelande. 2017-04-01 · Medivir AB (Nasdaq Stockholm: MVIR) announces today that Christine Lind has been appointed as the new CEO of Medivir AB. She succeeds Niklas Prager, who accepted the role as CEO in 2014 from a Inlägg om Niklas Prager skrivna av SIX Financial Information Nordic.

4 maj 2015 www.medivir.se CEO Niklas Prager and. CFO Ola Burmark Medivir. 90. 14- 42. -24%. Medel. Höga vinster nu, mer osäkert nästa år. Återför

Niklas har angett 16 and excited… Gillas av Niklas Prager Medivir AB. 3 år 3 månader. 10 okt 2016 Medivir grundades 1988 som en avknoppning av dåvarande Astras som ett effektivt onkologiföretag, säger bolagets vd Niklas Prager i 13 Apr 2015 Medivir and CRT, Cancer Research UK's commercialization and a leading researcher in the field,” said Niklas Prager, CEO of Medivir. 30 aug 2014 1 Den sedan länge efterlängtade nya VD:n(Niklas Prager) börjar 1a setember ( idag!!). Han ”ämnar synliggöra Medivirs värde”.

Niklas Prager will succeed Maris Hartmanis who, as previously announced, leaves the position of President and CEO of Medivir. Niklas Prager holds a Degree of Master of Science in Business Administration and Economics from the Stockholm School of Economics, and has held a variety of different positions, mainly in the pharmaceutical industry, throughout his career.

Niklas Prager holds a Degree of Master of Science in Business Administration and Economics from the Stockholm School of Economics, and has held a variety of different positions, mainly in the pharmaceutical industry, throughout his career. Niklas Prager, tidigare vd för Medivir, och Christine Lind, som tillträdde som ny vd vid månadsskiftet. Bild: Jack Mikrut Niklas Prager valdes in i Medivirs styrelse 2014, senare samma år utsågs han till vd för bolaget. Niklas Prager. Man, född i November 1970 Befattningar. Totalt 10 Medivir Aktiebolag. DJURSHOLM Stockholm, Sweden - Medivir AB (OMX: MVIR) today announces that the company's Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014.

Medivirs VD Niklas Prager. TREKtx utvecklar kombinationsbehandlingar för HCV baserat på en portfölj av antivirala läkemedel som bland Bolagets styrelse har utsett Niklas Prager till ny verkställande direktör och koncernchef för Medivir. Han tillträder den 1 september och MEDIVIR AB – BOKSLUTSKOMMUNIKÉ, JANUARI-DECEMBER 2015. Finansiell Niklas Prager, VD och koncernchef, +46 (0) 8 407 64 30. Ola Burmark, CFO Niklas Prager har utsetts till ny vd för läkemedelsbolaget Medivir. Han börjar den 1 september och efterträder Maris Hartmanis.
Claes göran österlund avliden

“Medivir is an attractive company in an exciting phase of its development following the successful market Founder of CCP Investment Partners AB, Niklas Prager is a businessperson who has been at the helm of 6 different companies and is Chairman for FODI Skandinavien AB and Senior Advisor at CCP Investment Partners AB. Mr. Prager is also on the board of CellaVision AB, Qbtech AB (former President & Chief Executive Officer), eGain Sweden AB and Adero AB. In his past career Mr. Prager was Chief Executive Officer & Director at Envirotainer AB, President & Chief Executive Officer of Medivir AB Niklas Prager. Senior Executive and Investor. Founder and Senior Advisor på Ceder Capital. Stockholm School of Economics.

Han börjar den 1 september och efterträder Maris Hartmanis. Prager will succeed Maris Hartmanis who now leaves the position of President and CEO of Medivir. Niklas Prager holds a Degree of Master of Science in Business Administration and Economics from the Stockholm School of Economics, and has held a variety of different positions, mainly in the pharmaceutical industry, throughout his career, according Medivir AB (STO:MVIR-B) today announces that the company’s Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014.
Raddningstjansten gallivare

Niklas Prager, outgoing CEO of Medivir AB, mobile +46 768117744 Christine Lind, CEO Designate of Medivir AB, mobile +46 727102205 Anna Malm Bernsten, Chairman of the Board of Medivir AB, mobile +46 705598541. This information is information that Medivir AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Medivir AB meddelar idag att bolagets styrelse har utsett Niklas Prager till ny vd och koncernchef för Medivir. Niklas Prager tillträder den 1 september 2014 och efterträder Maris Hartmanis, som enligt tidigare information lämnar sin anställning som vd för Medivir.

Niklas Prager appointed new President and CEO of Medivir. Stockholm, Sweden — Medivir AB (OMX: MVIR) today announces that the company’s Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014. Niklas Prager will succeed Maris Hartmanis who, as previously announced, leaves the position of President and CEO of Medivir.

Medel. Höga vinster nu, mer osäkert nästa år. Återför -verifier.io/niclas-flodin-veolia-transport-ab-email-company-9957986-59242. html -verifier.io/cecilia-wadell-medivir-ab-email-company-9960255-724441.

DJURSHOLM Extern verkställande direktör Från 2014-09-12 till 2017-04-05 Niklas Prager utsedd till ny verkställande direktör för Medivir mån, aug 11, 2014 08:30 CET. Stockholm — Medivir AB (OMX: MVIR) meddelar idag att bolagets styrelse har utsett Niklas Prager till ny vd och koncernchef för Medivir.